Management Team

IntegriChain’s leadership team has brought together veteran Pharma and BioPharma executives with proven informatics innovators. Our combined experiences enable us to connect with our customers’ unique challenges while sustaining the entrepreneurial spirit that remains critical to our success.

Kevin E. Leininger

Co-Founder & Chief Executive Officer

As Chief Executive Officer, Kevin is responsible for corporate management and leadership, strategic planning, organizing and coordination of the executive management team. He has spent the last 20 Read More > years building and launching software and services companies in the financial services, petroleum and pharmaceutical industries, some leading to IPOs. He has authored six books on Unix, the Internet and Java and has spoken at conferences and seminars around the world. Kevin holds a BS in Physics from Iowa State University and an MBA in International Business and Finance from the University of Chicago. Show Less
Joshua I. Halpern

Co-founder & VP, Marketing & Business Dev.

Josh Halpern is responsible for strategic product direction, product marketing, pricing, and new market entry. Previously, Josh was Vice President of Business Development for Internet Crimes Group, Read More > a data mining and analytics firm specializing in intellectual property and brand protection. At Internet Crimes Group, Josh successfully introduced new applications of the company’s platform in the pharmaceutical industry and in consumer markets. Josh is a leading expert in pharmaceutical channel information and is a regular speaker at industry and government conferences and seminars. Josh is a graduate of Princeton University with a degree in History. Show Less
Dennis O’Malley

Vice President, Customer Operations

Dennis O'Malley is responsible for customer operations including project delivery, program management and data center operations. Previously, Dennis was the Chief Operating Officer of Acsis, Inc., a Read More > supply chain software company dealing primarily in the pharmaceutical and chemical markets. Dennis served as a Vice President at Checkpoint Systems Inc. a world leader in retail loss prevention, managing over 600 employees. During his tenure, Checkpoint grew from $35 million to $350 million. Dennis is a graduate of the Rutgers University School of Business with a degree in Business Management. Show Less
Darren Weiss

Vice President & Chief Financial Officer

Darren Weiss is responsible for the company's finances, administration and strategic planning. Over the past 18 years Darren has held various finance and accounting roles, most recently as CFO of a Read More > UK plc, and has experience in Initial Public Offerings, Secondary Offerings, Rights Offerings and issuance of various debt instruments. Darren began his career in public accounting with experience in KPMG’s Healthcare and Life Sciences practice based in Philadelphia. Darren holds BS in Accounting from Syracuse University and earned his CPA in Pennsylvania. Show Less
Jeffrey M. Borman

Vice President, Advanced Analytics

Jeff Borman is responsible for IntegriChain’s advanced analytic offerings. He has spent 20 years in the pharmaceutical industry developing a background in product commercialization, opportunity Read More > identification, commercial strategy development, and forecasting. Prior to joining IntegriChain, Jeff was responsible for Endo Pharmaceuticals’ Business Information group where he worked with IntegriChain on a number of key analytic initiatives. Jeff has held senior sales and marketing roles at Abbott Laboratories and AstraZeneca Pharmaceuticals. Jeff received his MBA from the University of Wisconsin, Oshkosh, and a Bachelor of Science from the University of Wisconsin, Stevens Point. He is an active member of PMSA and PMRG. Show Less
Daniel P. Kinney

Vice President, Information Services

Daniel Kinney is responsible for Enriched Channel Sales, IntegriChain’s outlet master and metadata, and related new product offerings. Previously, Danny was Executive Director of Worldwide Read More > Business Intelligence at Bristol-Myers Squibb, a leading pharmaceutical company. At Bristol-Myers, Danny led the team responsible for identifying, acquiring, and managing sales, prescription, and patient-level data, and for developing reporting and analytic solutions for the commercial pharmaceutical organization. Danny is a graduate of Princeton University with a degree in Economics, and the Columbia School of Business, with concentrations in Finance and International Business. Show Less